Received CE mark for innovative robotic HIFU device Focal One ® Eliminated all outstanding long-term debt and strengthened financial profile Publication of long-term study reporting 10 year cancer-specific survival and metastatic-free survival rates for prostate cancer patients treated with
LYON, France , Aug. 26, 2013 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by EDAP TMS SA (Nasdaq:EDAP), please note that the presentation time should be 10:50 am ET — 11:15 am ET , rather than 10:25 am ET — 10:50 am ET as originally stated.
LYON, France , Aug. 13, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2013 results announcement, which will take place on Wednesday, August 28, 2013 , before the opening of the market.
Closes $12.0 Million Placement to Fully Redeem $8.0 Million Long-Term Debt Positions Company to Invest in Expansion of U.S. Operations LYON, France , May 29, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, outlined today the strengthening of its
LYON, France , May 21, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced that it has entered into definitive agreements with certain institutional investors for a registered direct placement of $12 million of ordinary shares in the form of
First quarter 2013 revenue rose 23% to EUR 5.9 million ( USD 7.8 million ) Continuing US investments in both FDA regulatory process and US operations Great momentum and success achieved at two of the world major urology congresses for EDAP's advanced technologies Publication of two independent
Four Scientific Sessions Highlighted HIFU for Treatment of Prostate Cancer HIFU Featured in Plenary Lecture and Two Moderated Posters at Engineering and Urology Society Meeting Significant Interest in both HIFU and ESWL Technologies at EDAP Booth LYON, France , May 14, 2013 (GLOBE NEWSWIRE) -- EDAP
